Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biocharacteristics shared by highly protective vaccines against Marek's disease

30 Dec 2003

Abstract excerpt

Attenuated serotype 1 Marek's disease virus strains vary widely in their protection properties. This study was conducted to elucidate which biocharacteristics of serotype 1 MDV strains are related with protection. Three pairs of vaccines, each one including a higher protective (HP) vaccine and a lower protective (LP) vaccine originating from the same MDV strain, were studied. Two other highly protective vaccines...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Herpesvirus Infections and Treatments
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14681069
DOI: 10.1080/0307945031000163264

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biocharacteristics shared by highly protective vaccines against Marek's diseasePMID 14681069Read ↗

Serotype 1 Viruses Modified by Backpassage or Insertional Mutagenesis: Approaching the Threshold of Vaccine Efficacy in Marek's DiseaseSemantic proximity Read ↗

Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infectionSemantic proximity Read ↗

Assessment on Different Vaccine Formulation Parameters in the Protection against Heterologous Challenge with FMDV in CattleSemantic proximity Read ↗

Fully Attenuated meq and pp38 Double Gene Deletion Mutant Virus Confers Superior Immunological Protection against Highly Virulent Marek’s Disease Virus InfectionSemantic proximity Read ↗

Marek's disease herpesvirus vaccines integrate into chicken host chromosomes yet lack a virus-host phenotype associated with oncogenic transformation.Semantic proximity Read ↗

Syngeneic Marek's Disease Virus (MDV)-Specific Cell-Mediated Immune Responses against Immediate Early, Late, and Unique MDV ProteinsSemantic proximity Read ↗

Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.Semantic proximity Read ↗

Replication-Competent Bacterial Artificial Chromosomes of Marek's Disease Virus: Novel Tools for Generation of Molecularly Defined Herpesvirus VaccinesSemantic proximity Read ↗

A Toll-Like Receptor 3 Ligand Enhances Protective Effects of Vaccination Against Marek's Disease Virus and Hinders Tumor Development in ChickensSemantic proximity Read ↗

Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.Semantic proximity Read ↗

Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.Semantic proximity Read ↗

Influence of B-Haplotype on the Relative Efficacy of Marek's Disease Vaccines of Different SerotypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.